At WntRx Pharmaceuticals, we use cutting-edge technology to develop non-toxic, oncogenic specific, first-in-class Wnt inhibitors.

WntRx Pharmaceuticals Inc. focuses on early stage research and development of cancer drugs. Led by a seasoned management team utilizing cutting-edge technology, our scientists are dedicated to developing innovative peptide drugs to alleviate pain and increase survival rate in order to fulfill our ultimate vision: shaping a better life for the patient.